Litcius/Paper detail

Pralsetinib: First Approval

Anthony Markham

2020Drugs101 citationsDOI

Topics & Concepts

MedicineThyroid carcinomaMedullary thyroid cancerVandetanibThyroid cancerLung cancerOncologyPapillary thyroid cancerCancerInternal medicineThyroidCancer researchSorafenibHepatocellular carcinomaLung Cancer Treatments and MutationsChronic Myeloid Leukemia TreatmentsChronic Lymphocytic Leukemia Research
Pralsetinib: First Approval | Litcius